# EDGAR Filing Document

**Accession Number:** 0001636422
**File Stem:** 0001636422-23-000007
**Filing Date:** 2023-1
**Character Count:** 8281
**Document Hash:** f5c448d063a4f0eefb0b945894045bc1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001636422-23-000007.hdr.sgml**: 20230106

**ACCESSION NUMBER**: 0001636422-23-000007

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20221230

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230106

**DATE AS OF CHANGE**: 20230106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Health Catalyst, Inc.
- **CENTRAL INDEX KEY:** 0001636422
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
- **IRS NUMBER:** 453337483
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38993
- **FILM NUMBER:** 23515955

**BUSINESS ADDRESS:**
- **STREET 1:** 10897 SOUTH RIVER FRONT PARKWAY, #300
- **CITY:** SOUTH JORDAN
- **STATE:** UT
- **ZIP:** 84095
- **BUSINESS PHONE:** 801-708-6800

**MAIL ADDRESS:**
- **STREET 1:** 10897 SOUTH RIVER FRONT PARKWAY, #300
- **CITY:** SOUTH JORDAN
- **STATE:** UT
- **ZIP:** 84095

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HQC Holdings, Inc.
- **DATE OF NAME CHANGE:** 20150312

?xml version="1.0" ? hcat-20221230

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**_________________________________________________________**

**FORM 8-K**

**__________________________________________________________**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): December 30, 2022**

**__________________________________________________________**

**HEALTH CATALYST, INC.**

(Exact name of registrant as specified in its charter)

**________________________________________________________________**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-38993** | **45-3337483** |
| (State or other jurisdiction of<br>incorporation) | (Commission File Number) | (IRS Employer<br>Identification No.) |

---

**10897 South River Front Parkway #300**

**South Jordan, UT 84095** 

(Address of principal executive offices, including zip code)

**(801) 708-6800**

(Registrant's telephone number, including area code)

**Not Applicable** 

(Former name or former address, if changed since last report)

**______________________________________________________________**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**______________________________________________________________**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of exchange on which registered |
| **Common Stock, par value $0.001 per share** | **HCAT** | **The Nasdaq Global Select Market** |

---

**________________________________________________________**

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ((§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On December 30, 2022, Paul Horstmeier provided notice to Health Catalyst, Inc. (the "Company") that he will step down from his position as Chief Operating Officer of the Company, effective March 31, 2023 (the "Separation Date"), due to Mr. Horstmeier being called by the leadership of the Church of Jesus Christ of Latter-Day Saints to serve for 3 years as Mission President of the Puerto Rico San Juan Mission, beginning in June 2023. Mr. Horstmeier's departure is not the result of any disagreement or conflict with the Company. At the current time, Mr. Horstmeier's responsibilities will transition to certain members of the Company's leadership. To help ensure a smooth transition of his responsibilities, Mr. Horstmeier will continue to be employed by the Company on a full-time basis through the Separation Date and, thereafter, will support the Company as a senior advisor.

A copy of the press release issued by the Company on January 6, 2023 regarding the transition of Mr. Horstmeier is attached hereto as Exhibit 99.1.

**Item 9.01. Financial Statements and Exhibits.**

(d) <u>Exhibits.</u>

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| <u>[99.1](exhibit991-pressreleaselea.htm)</u> | <u>[Press release issued by Health Catalyst, Inc. on January 6, 2023](exhibit991-pressreleaselea.htm)</u> |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | **HEALTH CATALYST, INC.** |
| Date: January 6, 2023 | By: | /s/ Bryan Hunt |
|  |  | Bryan Hunt |
|  |  | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![healthcatalystlogo1aa.jpg](healthcatalystlogo1aa.jpg)

**Health Catalyst Announces New, External Leadership Assignment for Paul Horstmeier**

**Salt Lake City, UT – January 6, 2023 –** Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that the leadership of the Church of Jesus Christ of Latter-Day Saints has called Paul Horstmeier, Health Catalyst's Chief Operating Officer, to serve for three years as the Mission President of the Puerto Rico San Juan Mission, beginning in late June 2023.

As a result, Mr. Horstmeier will transition from his full-time position as Chief Operating Officer, effective March 31, 2023, to that of a Senior Advisor. Mr. Horstmeier will continue working closely with Dan Burton, CEO of Health Catalyst, to transition his responsibilities to other senior leaders at Health Catalyst in the coming months.

"Paul's contributions to Health Catalyst's growth and success over the past 11 ½ years have been enormous and deeply impactful," said Mr. Burton. "Paul will be sorely missed as he and his wife Karryl serve the missionaries and people of Puerto Rico during their three-year tenure, but I have no doubt of the positive effect of their sacrifice and service, and we look forward to welcoming Paul back full-time to Health Catalyst after the conclusion of this mission assignment."

This is the second time a member of Health Catalyst's Senior Leadership Team has been called to serve as a Mission President for the Church of Jesus Christ of Latter-Day Saints. From 2017 to 2020, Health Catalyst Co-Founder Steve Barlow was called to serve as a Mission President in Ecuador, which necessitated his transition for three years, followed by his subsequent return to Health Catalyst in the fall of 2020. Health Catalyst, as a mission-driven organization, is grateful for and supportive of the many contributions its team members make in providing various types of volunteer service to the broader community.

**About Health Catalyst**

**Media Contact:**

Tarah Neujahr Bryan, Chief Marketing Officer

media@healthcatalyst.com

<br>